Anti-CCR2 monoclonal antibody MLN1202
| Anti-CCR2 monoclonal antibody MLN1202 | |
|---|---|
| Term | Anti-CCR2 monoclonal antibody MLN1202 |
| Short definition | anti-CCR2 monoclonal antibody MLN1202 (AN-Tee. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
anti-CCR2 monoclonal antibody MLN1202 - (pronounced) (AN-Tee. . . MAH-noh-KLOH-nul AN-Tee-BAH-dee. . . ) substance being studied for the treatment of atherosclerosis (a build-up of fat in the arteries). It is also being studied in the treatment of cancer that has spread to the bones. The anti-CCR2 monoclonal antibody MLN1202 attaches to a protein called CCR2, which is found on the surface of certain bone cells, white blood cells and cancer cells. The anti-CCR2 monoclonal antibody MLN1202 blocks the action of a substance involved in maintaining healthy bone mass. It can help prevent cancer cells from spreading to the bone and growing there. It's a type of monoclonal antibody. Also called MLN1202
External links
- Medical encyclopedia article on Anti-CCR2 monoclonal antibody MLN1202
- Wikipedia's article - Anti-CCR2 monoclonal antibody MLN1202
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski